These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30422039)

  • 41. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies.
    Kuter DJ; Begley CG
    Blood; 2002 Nov; 100(10):3457-69. PubMed ID: 12411315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
    Kühne T; Imbach P
    Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management.
    Scharf RE
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet Dysfunction: Status of Thrombopoietin in Thrombocytopenia Associated with Chronic Liver Failure.
    Giannini EG; Peck-Radosavljevic M
    Semin Thromb Hemost; 2015 Jul; 41(5):455-61. PubMed ID: 26049067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study.
    Kawaguchi T; Komori A; Seike M; Fujiyama S; Watanabe H; Tanaka M; Sakisaka S; Nakamuta M; Sasaki Y; Oketani M; Hattori T; Katsura K; Sata M
    J Gastroenterol; 2012 Dec; 47(12):1342-51. PubMed ID: 22674141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel approach to the evaluation of bleeding-related episodes in patients with chronic immune thrombocytopenia.
    Weitz I; Sanz MA; Henry D; Schipperus M; Godeau B; Northridge K; Gleeson M; Danese M; Deuson R
    Curr Med Res Opin; 2012 May; 28(5):789-96. PubMed ID: 22494019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects and serum levels of thrombopoietin in a case of chronic thrombocytopenia with achondroplasia.
    Ishiguro A; Nakahata T; Muraoka K; Tahara T; Miyazaki H; Kato T; Inaba Y; Shimbo T
    Int J Hematol; 1997 Jul; 66(1):99-102. PubMed ID: 9220665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of thrombopoietic agents for the thrombocytopenia of liver disease.
    Tillmann HL; McHutchison JG
    Semin Hematol; 2010 Jul; 47(3):266-73. PubMed ID: 20620438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review article: thrombocytopenia in chronic liver disease.
    Poordad F
    Aliment Pharmacol Ther; 2007 Nov; 26 Suppl 1():5-11. PubMed ID: 17958514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment Options for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing a Scheduled Procedure.
    Saab S; Bernstein D; Hassanein T; Kugelmas M; Kwo P
    J Clin Gastroenterol; 2020 Jul; 54(6):503-511. PubMed ID: 32195771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of Lusutrombopag in Patients with Mild to Moderate Thrombocytopenia.
    Tsuji Y; Kawaratani H; Ishida K; Kaya D; Kubo T; Fujinaga Y; Sawada Y; Takaya H; Shimozato N; Kaji K; Namisaki T; Moriya K; Akahane T; Yoshiji H
    Dig Dis; 2020; 38(4):329-334. PubMed ID: 31655803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombopoietin and thrombocytopenia in anorexia nervosa with severe liver dysfunction.
    Yoshiuchi K; Takimoto Y; Moriya J; Inada S; Akabayashi A
    Int J Eat Disord; 2010 Nov; 43(7):675-7. PubMed ID: 19810087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
    Makar RS; Zhukov OS; Sahud MA; Kuter DJ
    Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia.
    Kuter DJ
    Annu Rev Med; 2009; 60():193-206. PubMed ID: 19642221
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease:
    Tanaka K; Baba T; Yoshida M; Iguchi M; Sonoyama T; Fukuhara T; Kano T
    Curr Med Res Opin; 2022 Feb; 38(2):303-310. PubMed ID: 34904508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures.
    Ding Z; Wu H; Zeng Y; Kuang M; Yang W; Meng Z; Chen Y; Hao C; Zou S; Sun H; Liu C; Lin K; Shi G; Wang X; Fu X; Chen R; Chen Y; Liang R; Kano T; Pan H; Yang S; Fan J; Zhou J
    Hepatol Int; 2023 Feb; 17(1):180-189. PubMed ID: 36258065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombopoietin receptor agonists in primary immune thrombocytopenia.
    Siegal D; Crowther M; Cuker A
    Semin Hematol; 2013 Jan; 50 Suppl 1(0 1):S18-21. PubMed ID: 23664510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokines for the treatment of thrombocytopenia.
    Ciurea SO; Hoffman R
    Semin Hematol; 2007 Jul; 44(3):166-82. PubMed ID: 17631181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Avatrombopag for the treatment of immune thrombocytopenia.
    Długosz-Danecka M; Zdziarska J; Jurczak W
    Expert Rev Clin Immunol; 2019 Apr; 15(4):327-339. PubMed ID: 30799645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study.
    Wang YS; Wang W; Zhang S; Zhang SY; Shen AZ; Wang W; Song HC; Yao HZ; Song RP; Meng FZ; Li L; Nashan B; Wang JZ; Liu LX
    Front Pharmacol; 2022; 13():1009612. PubMed ID: 36267268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.